ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.65
USD
-0.08 (-0.15%)
Streaming Delayed Price
/ Updated:
10:09 AM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about GlaxoSmithKline PLC ADS
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting
Today 9:46 EDT
Battle lines are being drawn two weeks before a highly unusual two-day FDA advisory committee meeting to discuss the contentious diabetes drug rosiglitazone (Avandia, GlaxoSmithKline). This will be the...
Read More
category
NYSE:GSK
from
Forbes Real Time
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia
May 23, 2013
This morning, I published a guest post from Steven Nissen, Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic, alleging that the most likely rationale for an upcoming panel...
Read More
category
NYSE:GSK
from
Forbes Real Time
The FDA Responds To Steve Nissen's Criticism Of Upcoming Avandia Meeting
May 23, 2013
This morning, I published a guest post from Steven Nissen, Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic, alleging that the most likely rationale for an upcoming panel...
Read More
category
NYSE:GSK
from
Forbes Real Time
UPDATE 2-Elan rejects Royalty's $6.4 bln raised offer
May 23, 2013
* Elan says new bid continues to grossly undervalue company
Read More
category
companyNews
from
Reuters: Company News
4 Contagion Plays
May 23, 2013
In late March news out of China revealed that a new strain of bird flu was spreading to humans. Medical experts worldwide were alarmed, but it barely registered among investors—especially in the U.S....
Read More
category
NYSE:NVS
,
NYSE:SNY
,
NYSE:GSK
, and 1 more.
from
Forbes Real Time
Pharma Continues To Seek External R&D Funding, This Time from The Government
May 23, 2013
Read More
category
NYSE:PFE
,
NYSE:GSK
from
Forbes Real Time
Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings
May 23, 2013
This post was written by Steven E. Nissen MD, the Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic. This commentary expresses his personal opinions and not necessarily the...
Read More
category
NYSE:GSK
from
Forbes Real Time
GSK flu shot may raise adult narcolepsy risk -Finnish scientists
May 23, 2013
HELSINKI/LONDON, May 23 (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National...
Read More
category
companyNews
from
Reuters: Company News
Pfizer takes its shot at a vaccine for evasive superbug
May 23, 2013
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...
Read More
from
FOX News
GlaxoSmithKline: The Winning Streak Continues (GSK)
May 21, 2013
from
Comtex SmarTrend® News Briefs
GSK Says Lowering Prices in China Caused Higher Sales
May 21, 2013
Want to increase revenues in China? You might try lowering prices. It seems to have worked for GlaxoSmithKline. In 2009, the company reduced the cost of its allergy treatment, Avamys nasal spray. The...
Read More
from
ChinaBio® Today
From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers
May 21, 2013
from
Business Wire News Releases
Introducing The New Global Citizen: A Leadership Chronicle
May 21, 2013
category
International volunteer
,
GlaxoSmithKline
,
CDC Development Solutions
, and 5 more.
from
3BL Media: Corporate Social Responsibility, Energy and Health News
Impax board steps in to oversee Hayward manufacturing issues
May 20, 2013
category
Management
,
Biotech
,
GlaxoSmithKline
, and 9 more.
from
Business Journals
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story.
Read More
from
StreetInsider.com News Articles
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
category
AZN
,
ABBV
,
TSPT
, and 5 more.
from
YCharts
(GSK) GlaxoSmithKline’s Trametinib Delayed
May 16, 2013
Recently, GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Athersys Inc
,
Healthcare
, and 5 more.
from
Stock Blog Hub
Stepping into the Data Frontier
May 16, 2013
category
clinical trials
,
website
,
researcher
, and 4 more.
from
3BL Media: Corporate Social Responsibility, Energy and Health News
Chief executives and the itch to quit
May 16, 2013
LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds".
Read More
category
companyNews
from
Reuters: Company News
Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8343832 for the full story.
Read More
from
StreetInsider.com News Articles
(IPXL) Impax Laboratories Beats Earnings Estimate
May 15, 2013
Impax Laboratories Inc.’s (IPXL) first quarter 2013 adjusted earnings of 37 cents per share were... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Transcept Pharmaceuticals Inc
,
CPRX
, and 7 more.
from
Stock Blog Hub
19 Foreign Stocks With Cheap Valuation And Good Yields
May 15, 2013
category
Unassigned
,
Gold & Silver
from
Trefis
Biotech Drug Royalty Deal
May 14, 2013
Elan Corporation's (NYSE: ELN) has worked to soothe investor concern, and it's also added drug royalties to the company's assets...
Read More
from
Wealth Daily
Companies receiving the most NC tax breaks
May 14, 2013
category
Time Warner Cable
,
Target
,
Cree
, and 11 more.
from
Business Journals
GlaxoSmithKline Is Near a Key Resistance Area
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $52.54. The stock ended the trading session at just $51.67, which...
Read More
from
TradersHuddle.com
Market Wrap: Retail Sales Rip in April; Theravance, Elan Enter $1B Deal; Petrobras' Record Debt Sale
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8332964 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St ends near flat after recent gains; healthcare climbs
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks ended flat on Monday, pausing after hitting record highs last week, but strength in healthcare issues helped to keep declines in check.
Read More
category
companyNews
from
Reuters: Company News
US STOCKS-Wall St near flat after recent gains; retail data helps
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks were little changed on Monday as investors stepped back following last week's new highs, but stronger-than-expected retail sales data limited declined.
Read More
category
companyNews
from
Reuters: Company News
Notable 52-Week Highs and Lows of the Day 05/13: (TSLA) (THRX) (FSLR) High; (GNVC) (ANV) Low
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331715 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St flat after retail sales, Nasdaq edges higher
May 13, 2013
* Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3 pct
Read More
category
companyNews
from
Reuters: Company News
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
3
Pre-Market Primer: Durable Goods Orders Soar, but Markets Are Still Soft
Vincent Trivett
4
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
5
The End of the Road for Bulls, or Just a Healthy Correction?
Jason Haver
See All Articles
»